NO904168L - Nye imidazolpropanamidderivater, deres fremstilling og anvendelse. - Google Patents

Nye imidazolpropanamidderivater, deres fremstilling og anvendelse.

Info

Publication number
NO904168L
NO904168L NO90904168A NO904168A NO904168L NO 904168 L NO904168 L NO 904168L NO 90904168 A NO90904168 A NO 90904168A NO 904168 A NO904168 A NO 904168A NO 904168 L NO904168 L NO 904168L
Authority
NO
Norway
Prior art keywords
imidazolpropanamide
derivatives
preparation
new
new imidazolpropanamide
Prior art date
Application number
NO90904168A
Other languages
English (en)
Norwegian (no)
Other versions
NO904168D0 (no
Inventor
Alain Commercon
Jean-Marc Paris
Xavier Radisson
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of NO904168D0 publication Critical patent/NO904168D0/no
Publication of NO904168L publication Critical patent/NO904168L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C07D233/08—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
    • C07D233/12—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D233/16—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C07D233/08—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
    • C07D233/12—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D233/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/46—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/52—Nitrogen atoms not forming part of a nitro radical with hetero atoms directly attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO90904168A 1989-09-26 1990-09-25 Nye imidazolpropanamidderivater, deres fremstilling og anvendelse. NO904168L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8912574A FR2652351A1 (fr) 1989-09-26 1989-09-26 Nouveau derive de l'imidazolepropanamide, sa preparation et son emploi.

Publications (2)

Publication Number Publication Date
NO904168D0 NO904168D0 (no) 1990-09-25
NO904168L true NO904168L (no) 1991-03-27

Family

ID=9385817

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90904168A NO904168L (no) 1989-09-26 1990-09-25 Nye imidazolpropanamidderivater, deres fremstilling og anvendelse.

Country Status (9)

Country Link
JP (1) JPH03120258A (ja)
CA (1) CA2026128A1 (ja)
FI (1) FI904707A0 (ja)
FR (1) FR2652351A1 (ja)
HU (1) HU906213D0 (ja)
IE (1) IE903449A1 (ja)
IL (1) IL95761A0 (ja)
NO (1) NO904168L (ja)
PT (1) PT95419A (ja)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585020B1 (fr) * 1985-07-18 1987-10-02 Rhone Poulenc Sante Nouvelle substance biologiquement active, appelee girolline, extraite de l'eponge pseudaxinyssa cantharella, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
IE903449A1 (en) 1991-04-10
IL95761A0 (en) 1991-06-30
PT95419A (pt) 1991-05-22
HU906213D0 (en) 1991-03-28
FR2652351A1 (fr) 1991-03-29
NO904168D0 (no) 1990-09-25
JPH03120258A (ja) 1991-05-22
FI904707A0 (fi) 1990-09-25
CA2026128A1 (fr) 1991-03-27

Similar Documents

Publication Publication Date Title
NO905354L (no) Nye glykopolypeptidderivater og fremgangsmaate for deres fremstilling.
DK374389A (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
NO902661D0 (no) Ribozymer, deres fremstilling og anvendelse.
NO902658D0 (no) N-fenylpyrazolderivater, preparater og anvendelse derav.
DK609489D0 (da) Imidazolderivater, deres fremstilling og anvendelse
NO900469D0 (no) Piperidinforbindelser, deres fremstilling og anvendelse.
DK462187D0 (da) Pyridinyl-pyrimidin-derivater, deres fremstilling og anvendelse.
NO893886L (no) Nye aminokinolinforbindelser og fremgangsmaate for deres fremstilling.
DK388989D0 (da) Acylcyanoguanidiner, deres fremstilling og anvendelse
DK435289A (da) Piperazindioner, deres fremstilling og anvendelse
NO903978D0 (no) Pyridinyl-kinolonforbindelser, deres fremstilling og bruk.
NO903169L (no) 4,1,2-1h-benzoksadiaziner og deres fremstilling.
DK225089A (da) 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse
NO902473D0 (no) Nye pyridobenzoindolderivater, deres fremstilling og preparater inneholdende forbindelsene.
DK469389A (da) Piperidinyl-imidazol-derivater, deres fremstilling og anvendelse
NO865004L (no) Nye 16,17-acetalsubstituerte pregnan-21-oinsyrederivater og fremgangsmaate for deres fremstilling.
DK610787D0 (da) Substituerede thienoimidazoltoluidin-derivater, deres fremstilling og anvendelse
DK592389A (da) Penemderivater, deres fremstilling og anvendelse
NO885020D0 (no) Isokinolinderivater, deres fremstilling og anvendelse.
NO904168L (no) Nye imidazolpropanamidderivater, deres fremstilling og anvendelse.
NO900275D0 (no) Benzopyranderivater, deres fremstilling og anvendelse i legemidler.
NO894821D0 (no) Homopolysakkarid, opploesning derav, og deres fremstillingog anvendelse.
DK602389D0 (da) Benzensulfonamidderivater, deres fremstilling og anvendelse
DK163589D0 (da) Sakyomycin e og derivater deraf, deres fremstilling og anvendelse
NO921390L (no) Indolderivater, deres fremstilling og anvendelse